These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 32487421)

  • 1. Progressive supranuclear palsy: Advances in diagnosis and management.
    Coughlin DG; Litvan I
    Parkinsonism Relat Disord; 2020 Apr; 73():105-116. PubMed ID: 32487421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigational therapeutics for the treatment of progressive supranuclear palsy.
    Coughlin DG; Litvan I
    Expert Opin Investig Drugs; 2022 Aug; 31(8):813-823. PubMed ID: 35695010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diagnosis of progressive supranuclear palsy: current opinions and challenges.
    Ali F; Josephs K
    Expert Rev Neurother; 2018 Jul; 18(7):603-616. PubMed ID: 29902389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches.
    Boxer AL; Yu JT; Golbe LI; Litvan I; Lang AE; Höglinger GU
    Lancet Neurol; 2017 Jul; 16(7):552-563. PubMed ID: 28653647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive supranuclear palsy.
    Giagkou N; Höglinger GU; Stamelou M
    Int Rev Neurobiol; 2019; 149():49-86. PubMed ID: 31779824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive supranuclear palsy: a current review.
    Lubarsky M; Juncos JL
    Neurologist; 2008 Mar; 14(2):79-88. PubMed ID: 18332837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive Supranuclear Palsy: an Update.
    Armstrong MJ
    Curr Neurol Neurosci Rep; 2018 Feb; 18(3):12. PubMed ID: 29455271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive supranuclear palsy: current approach and challenges to diagnosis and treatment.
    Veilleux Carpentier A; McFarland NR
    Curr Opin Neurol; 2023 Aug; 36(4):309-316. PubMed ID: 37381926
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Messerschmidt K; Barthel H; Brendel M; Scherlach C; Hoffmann KT; Rauchmann BS; Rullmann M; Marek K; Villemagne VL; Rumpf JJ; Saur D; Schroeter ML; Schildan A; Patt M; Beyer L; Song M; Palleis C; Katzdobler S; Fietzek UM; Respondek G; Scheifele M; Nitschmann A; Zach C; Barret O; Madonia J; Russell D; Stephens AW; Koglin N; Roeber S; Herms J; Bötzel K; Bartenstein P; Levin J; Seibyl JP; Höglinger G; Classen J; Sabri O;
    J Nucl Med; 2022 Nov; 63(11):1754-1760. PubMed ID: 35422444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive Supranuclear Palsy and Corticobasal Syndrome.
    Pantelyat A
    Continuum (Minneap Minn); 2022 Oct; 28(5):1364-1378. PubMed ID: 36222770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical value of CSF amyloid-beta-42 and tau proteins in Progressive Supranuclear Palsy.
    Schirinzi T; Sancesario GM; Di Lazzaro G; Scalise S; Colona VL; Imbriani P; Mercuri NB; Bernardini S; Lang AE; Pisani A
    J Neural Transm (Vienna); 2018 Sep; 125(9):1373-1379. PubMed ID: 29948175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive supranuclear palsy and multiple system atrophy: clinicopathological concepts and therapeutic challenges.
    Respondek G; Levin J; Höglinger GU
    Curr Opin Neurol; 2018 Aug; 31(4):448-454. PubMed ID: 29746401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and management of progressive supranuclear palsy.
    Litvan I
    Semin Neurol; 2001; 21(1):41-8. PubMed ID: 11346024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The phenotypic spectrum of progressive supranuclear palsy.
    Respondek G; Höglinger GU
    Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1():S34-6. PubMed ID: 26421392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic advances in multiple system atrophy and progressive supranuclear palsy.
    Poewe W; Mahlknecht P; Krismer F
    Mov Disord; 2015 Sep; 30(11):1528-38. PubMed ID: 26227071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive supranuclear palsy (PSP): Richardson syndrome and other PSP variants.
    Lopez G; Bayulkem K; Hallett M
    Acta Neurol Scand; 2016 Oct; 134(4):242-9. PubMed ID: 27070344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive supranuclear palsy: where are we now?
    Burn DJ; Lees AJ
    Lancet Neurol; 2002 Oct; 1(6):359-69. PubMed ID: 12849397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on progressive supranuclear palsy.
    Litvan I
    Curr Neurol Neurosci Rep; 2004 Jul; 4(4):296-302. PubMed ID: 15217544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Progressive supranuclear palsy: what's new?].
    Levy R
    Geriatr Psychol Neuropsychiatr Vieil; 2011 Jun; 9(2):191-201. PubMed ID: 21690028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive Supranuclear Palsy and Corticobasal Degeneration.
    Coughlin DG; Dickson DW; Josephs KA; Litvan I
    Adv Exp Med Biol; 2021; 1281():151-176. PubMed ID: 33433875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.